A promising treatment on the horizon for cancer-related fatigue
INTELWAR BLUF: A potential breakthrough discovery by Yale Cancer Center researchers reveals that a metabolism-targeting drug, dichloroacetate (DCA), could potentially alleviate cancer-related fatigue (CRF), a debilitating condition that many cancer…